Who
Gail Boudreaux
President and CEO
Company insider
Files Form 4 as: President and CEO, Elevance Health; Director, Target; Director, Zimmer Biomet Holdings; Director, Xcel Energy; Director, Novavax; EVP & CEO, UnitedHealthcare, UnitedHealth Group; Director, Genzyme.
In numbers
- Trades disclosed
- 280
- Buys
- 7
- Sells
- 9
- Bought
- $7.2M
- Sold
- $42.6M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 25 May 2006
- Last trade
- 17 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jul 2026filed 17 Jul 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $249K680 at $366.41 | filing |
| 17 Jul 2026filed 17 Jul 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $753K2,045 at $368.25 | filing |
| 17 Jul 2026filed 17 Jul 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $249K680 at $366.41 | filing |
| 17 Jul 2026filed 17 Jul 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $753K2,045 at $368.25 | filing |
| 11 Mar 2026filed 13 Mar 2026 | TGT TargetMass, Grocery & Drug Retail | SEC FORM 4 Code A | —2,682 at $0.00 | filing |
| 11 Mar 2026filed 13 Mar 2026 | TGT TargetMass, Grocery & Drug Retail | SEC FORM 4 Code A | —2,682 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $493K1,736 at $284.03 | filing |
| 3 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $493K1,736 at $284.03 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $2.0M6,713 at $294.07 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —16,153 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —10,527 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance Healthoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —63,818 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance Healthoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —63,818 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $2.0M6,713 at $294.07 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —16,153 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —10,527 at $0.00 | filing |
| 18 Jul 2025filed 18 Jul 2025 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $668K2,334 at $286.07 | filing |
| 18 Jul 2025filed 18 Jul 2025 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $1.5M5,116 at $287.12 | filing |
| 18 Jul 2025filed 18 Jul 2025 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $302K1,050 at $287.96 | filing |
| 12 Mar 2025filed 14 Mar 2025 | TGT TargetMass, Grocery & Drug Retail | SEC FORM 4 Code A | —2,946 at $0.00 | filing |
News
Elevance Health, Inc. (NYSE:ELV) to Issue Quarterly Dividend of $1.72ELV · themarketsdaily.com · 21 Oct 2026Elevance Health Raises 2026 Outlook As Third-Quarter Profit Tops Prior YearELV · rttnews.com · 21 Oct 2026Elevance Health reaches $425.27, completing a full-year round tripELV · 247wallst.com · 14 Oct 2026
0 headlines in the last 90 days name Gail Boudreaux; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.